Terveystalo stock

TTALO · Nasdaq Helsinki · EUR

Compare Terveystalo
€6.09Change from previous close: 0.00%

Close · November 17, 2026

Price history

−33.59% over the period

1 year: from €9.14 (November 17, 2025) to €6.07 (November 17, 2026), −33.59%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026€6.07
October 30, 2026€6.04
September 30, 2026€7.44
August 31, 2026€7.62
July 31, 2026€7.57
June 30, 2026€7.66
May 29, 2026€8.09
April 30, 2026€7.80
March 31, 2026€8.65
February 27, 2026€9.32
January 30, 2026€10.14
December 30, 2025€9.78
November 28, 2025€9.38
November 17, 2025€9.14

At a glance

  • The company

    Provides occupational healthcare services including general practice, specialist medical care, diagnostics, dental and digital health services across Finland, Sweden and Estonia

  • Latest results

    Quarter to September 30, 2026 · EPS €0.07 (estimate €0.11)

TickerLandia's take on Terveystalo

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€5.93
52-wk high€10.42

−41.55% from the 52-week high

Analysts · 3 analysts

Average target€7.17+17.68% vs. price

Buy 1 · Hold 1 · Sell 1

TickerLandia Fingerprint: Terveystalo

Compared with similar companies: very weak momentum, very low growth, and very low earnings stability.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Terveystalo is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Terveystalo's P/E today is 8.32, below the median of its last 8 fiscal years (22.7; between 13.4 and 148.3 from 2017 to 2025). Terveystalo's P/E (trailing 12 months): 13.5, −59% against the median of a group of 10 similar companies (32.9).

P/E compared with its history

Compared with 10 similar companies

Terveystalo's metrics compared with similar companies
MetricTerveystaloPosition in the groupBand
P/E (trailing 12 months)13.5Low
Forward P/E9.27Low
Operating margin8.9%Middle
ROE10.4%Middle
Debt/equity1.34Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Terveystalo. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€262.9M

Latest quarter · Q3 2026

Net income

€5.5M

Latest quarter · Q3 2026

Quarterly net margin

2.1%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
€772.27M
P/E
13.5
EPS
€0.45
Volume
138.63K
Daily trading
€1.46M
Dividend yield
15.76%
Last ex-dividend on October 7, 2026

How Terveystalo is changing

All results
  • Revenue grew 5.3% a year on average over the last 5 years

  • Operating margin rose from 5.3% to 11.5%

  • Profitable in 4 of 5 fiscal years

Returns

Terveystalo returns with dividends

€1,000 invested in Terveystalo 5 years ago, on November 17, 2021, would be worth €695 today with dividends reinvested: −30.46% in total, −7.01% per year. On price alone it would be €529 (−47.13%).

PeriodTerveystalo€1,000 becomes
1 month−9.54%€905
6 months−22.42%€776
Year to date−37.93%€621
1 year−24.89%€751
3 years+4.69%€1,047
5 years−30.46%€695

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Terveystalo: technical analysis

Terveystalo is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 51.5% below its all-time closing high (€12.56, September 6, 2021).

Trend
Downward
RSI (14 sessions)
34
Between 30 and 70
vs 200-session average
−22.75%

Support and resistance

Price areas where Terveystalo has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€7.61+24.90%3 touches, last on September 16, 2026
  2. Resistance€7.31+20.03%2 touches, last on June 18, 2026
  3. Resistance€6.30+3.45%2 touches, last on November 9, 2026
  4. Last price€6.09
  5. No support below: the price is near the lows of the year

Volatility and risk

Volatility (60 sessions, annualised)
28.4%
Largest fall in the last year
−42.36%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Terveystalo: seasonality

Average monthly price change over 9 years

+6.4%Jan−1.9%Feb−2.5%Mar+3.6%Apr+2.1%May−2.8%Jun−1.8%Jul+0.7%Aug−4.0%Sep−6.4%Oct+2.5%Nov+2.4%Dec

Over the last 9 years, the strongest month for Terveystalo has been January: +6.36% on average, positive in 8 years out of 9. The weakest has been October: −6.42% on average, positive in 3 years out of 9. November, the current month, has been positive in 5 years out of 9 (+2.48% on average).

Show chart data
MonthAverageMedianPositive years
January+6.36%+5.18%8 of 9
February−1.87%−2.73%4 of 9
March−2.51%+0.53%5 of 9
April+3.57%+0.51%5 of 9
May+2.06%+1.64%5 of 9
June−2.78%−3.26%2 of 9
July−1.80%−2.51%3 of 9
August+0.71%−1.67%4 of 9
September−4.02%−3.75%1 of 9
October−6.42%−5.57%3 of 9
November+2.48%+0.54%5 of 9
December+2.36%+4.26%6 of 9

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Terveystalo and its competitors

Occupational healthcare, general practice and dental care delivered under the Terveystalo name form the core of the business, alongside imaging and laboratory tests, child welfare services and outpatient surgery. Beyond these, the group sells healthcare outsourcing and staffing, remote and digital services, therapy and rehabilitation, and addiction prevention. Its customers include private individuals and families, corporate and consumer clients, insurance companies and public sector bodies, and it operates in Finland, Sweden and Estonia.

Headquarters
Helsinki, Finland
Employees
8,111
Founded
2001
Chief executive
Ville Iho
Terveystalo and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
TerveystaloTTALO$848.65M8.9%13.5−22.42%
Spire Healthcare GroupSPI$1.31B6.2%—+8.79%
MedicoverMCOV.B$3.88B7.4%38.5+28.68%
Fresenius Medical CareFME$11.77B10.3%12.1+6.69%
FreseniusFRE$29.53B9.8%17.2+38.53%
Mouwasat Medical Services4002$3.13B25.5%37.0−9.80%

Same industry or related industries, similar size. Compare Terveystalo with its competitors · Full profile